Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review
Life · 14.08.2026 · 16 (8) · 1338
DOI: 10.3390/life16081338 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 14.08.2026. Verfasst von Szabolcs Kéri. Beteiligte Einrichtung: Sztárai Institute, Tokaj-Hegyalja University, 3950 Sárospatak, Hungary. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Clinical trials and naturalistic studies describe psychedelics under markedly different exposure conditions. This narrative review searched PubMed/MEDLINE, the Cochrane Library, ClinicalTrials.gov, and regulatory sources through 15 July 2026, and examined safety and outcomes across four dimensions of exposure: dose, frequency, person, and context. In screened adults receiving one to three supervised doses, transient headache, nausea, anxiety, and cardiovascular activation are common; serious reactions are uncommon but include persistent anxiety, suicidality signals, and a recent case of hallucinogen persisting perception disorder. Evidence supports MDMA (3,4-Methylenedioxymethamphetamine) -assisted therapy for post-traumatic stress disorder and psilocybin-based interventions for depression, although functional unblinding, selected samples, inconsistent comparators, and a recent negative primary trial constrain certainty. Naturalistic studies suggest that vulnerability and context modify outcomes, but frequency is inconsistently measured and rarely linked to cumulative exposure or long-term health. Short-term microdosing trials show limited benefit, whereas long-term cardiac and psychiatric safety remains unresolved. Exposure-defined cohorts, prospective registries, echocardiographic surveillance, and blinding-aware comparative trials are priorities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sztárai Institute, Tokaj-Hegyalja University, 3950 Sárospatak, Hungary.
- Department of Physiology, Albert Szent-Györgyi Medical School, University of Szeged, 6720 Szeged, Hungary.
ORCID-Profile: Szabolcs Kéri
Zitieren
APA
Kéri, S. (2026). Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review. Life, 16(8), 1338. https://doi.org/10.3390/life16081338
Vancouver
Kéri S. Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review. Life. 2026;16(8):1338. doi:10.3390/life16081338
BibTeX
@article{Kri2026,
author = {Kéri, Szabolcs},
title = {Psychedelic Safety and Clinical Outcomes Across Exposure Patterns: A Structured Narrative Review},
journal = {Life},
year = {2026},
volume = {16},
number = {8},
pages = {1338},
doi = {10.3390/life16081338}
}
EUVIMED